LivingGLP1
Study S002091

Assessing Heart and Brain Metabolism in Type II Diabetes Mellitus Patients Using Carbon-13 MRI

ClinicalTrials.gov record

Registration

Registration
NCT07820722
Study type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Phase
EARLY_PHASE1
Masking
NONE
Status
NOT_YET_RECRUITING
Enrollment
32
Start
2026-10-01
Primary completion
2029-08-01
Lead sponsor
Sunnybrook Health Sciences Centre
Conditions
Diabete Type 2
Interventions
DRUG:C13 Hyperpolarized pyruvate injection
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Change in the 13C-pyruvate [At baseline and during the second MRI scan]
  • Changes in 13C-lactate [At baseline and during the second MRI scan]
  • Change in 13C-bicarbonate [At Baseline and during the second MRI scan]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.